Latest News & Features
Big Pharma
The $27.8 billion acquisition would allegedly enable the pharma giant to stifle competition for thyroid eye disease and chronic refractory gout treatments | There is currently no market competition for the treatments. 18 May 2023
article
The US Supreme Court knocks back Teva’s challenge to GSK’s damages win | Decision issued despite US solicitor general warning that the earlier decision ‘threatens significant harm’ to the market. 16 May 2023
article
Judge Albright awards punitive damages due to the 'intentional' nature of the infringement | Ravgen fails to secure a three-fold increase on damages awarded by a US jury last year. 16 May 2023
Big Pharma
The dispute centred on a treatment that helps people adjust their circadian rhythm | Path now clear for generic drug makers to unveil biosimilar versions of the drug. 11 May 2023
Big Pharma
Jury finds three US government patents over PrEP to be invalid | Case thought to be the first time US government has sued a pharmaceutical firm over patents. 11 May 2023
Americas
Decision addresses issue of plausibility in invalidation verdict |
Case marks first time that Court of Appeal judges held a patent with a single claim to a pharma compound invalid. 9 May 2023
article
The new CEO is currently Denmark CEO and group VP for the firm, who has ‘spearheaded international growth efforts’. 9 May 2023
Americas
Lawsuit concerns multibillion-dollar bone-strengthening drugs |
Alleged dearth of information provided to patent owner before biologics licence application was approved. 4 May 2023
Americas
Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x. 4 May 2023
article
Latest instalment in dispute over Apple Watch health functionality ends in mistrial | Verdict inconclusive as one out of seven jurors disagrees | Masimo had asked for more than $1.8 billion in damages. 2 May 2023